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ABSTRACT 
Long Lasting Insecticidal Nets (LLINs) are the most sustainable and effective malaria control tool 
currently available. Global targets are for ≥80% of the population living in malaria endemic areas 
to have access to and use a LLIN. However, current access to LLINs in endemic areas is 56% due 
to system inefficiencies and budget limitations. Thus, cost-effective approaches to maximize 
access of effective LLINs in endemic areas are required. This study evaluated whether LLINs that 
had been stored for more than five years under manufacturer recommended conditions may be 
optimally effective against Anopheles mosquitoes, to inform malaria control programs and 
governments on the periods over which LLINs may be stored between distributions, in an effort 
to maximise use of available LLINs. Standard World Health Organization (WHO) bioassays (cone 
and tunnel tests) were used to evaluate the bio-efficacy and wash resistance of Olyset® and 
DawaPlus® 2.0 (rebranded Tsara® Soft) LLINs after five years of storage at 25C - 33.4C and 
40%-100% relative humidity. In addition, a small scale Ifakara Ambient Chamber test (I-ACT) 
was conducted to compare bio-efficacy of one long stored LLIN to one new LLIN of the same 
brand, unwashed and washed. Long-lasting insecticidal nets were evaluated using laboratory 
reared fully susceptible Anopheles gambiae sensu stricto (s.s) (Ifakara strain) and pyrethroid 
resistant Anopheles arabiensis (Kingani strain). After five years of storage, both unwashed and 
washed Olyset® and DawaPlus® 2.0 LLINs passed WHO efficacy criteria on Knockdown (KD60) 
≥95%, 24-hr mortality ≥ 80% and ≥90% blood-feeding inhibition as per conducted WHO 
bioassays against susceptible An. gambiae s.s. The DawaPlus® 2.0 LLINs also passed combined 
WHO bio-assay criteria against resistant An. arabiensis. Confirmatory I-ACT test using whole 
nets demonstrated that long stored LLINs showed similar efficacy to new LLINs on both feeding 
inhibition and mortality endpoints against susceptible and resistant strains. Therefore, even after 
long storage of around 5 years, both Olyset® and DawaPlus® 2.0 remain efficacious against 
susceptible Anopheles mosquitoes at optimal storage range of 25C - 33.4C and 40%-100% 
relative humidity measured by standard WHO methods. DawaPlus® 2.0 remained efficacious 
against pyrethroid-resistant strain.  
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1.1Background of the Problem 
Malaria remains a public health problem globally. Deaths attributed by malaria were 435 000 and 
219 million cases globally in 2018 (WHO, 2018). Despite several interventions employed the 
global trend on malaria cases is  reported to be increasing in recent years (WHO, 2018). The 
largest burden of 93% malaria deaths and 92% malaria cases remain in Africa (WHO, 2018). 
Among of the various interventions commonly used to fight malaria in endemic areas, are Long-
lasting insecticidal nets (LLINs), Indoor-residual spraying (IRS) and drug treatment such 
Artemisinin-based combination therapy (ACT) (Agossa et al., 2018; Pryce, Richardson & 
Lengeler, 2018), these intervention have played big role on malaria reduction in endemic areas 
(Bhatt et al., 2015).  
Despite insecticide resistance, long-lasting insecticidal nets (LLINs) remain the most sustainable 
and effective malaria control tool available in endemic countries (Kleinschmidt et al., 2018; Pryce 
et al., 2018). Approximately 663 million cases of malaria, were prevented by LLINs since the 
year 2000, representing 68% of the total cases averted by all interventions used for malaria control 
(Bhatt et al., 2015). Mass distribution of LLINs after every three years, was recommended by 
WHO as the core element of the global malaria  strategy for malaria vector control in endemic 
areas (Khanam et al., 2018; Kilian, Koenker & Paintain, 2013; WHO, 2018). Between 2008 to 
2016, more than one billion LLINs were distributed in Africa through mass campaigns (Kilian et 
al., 2017). The wide scale up of LLINs distributions has led to significant reduction in malaria 
morbidity and mortality (Krezanoski, 2016). For a brand of LLIN to be listed as a potential 
product for mass campaign by the WHO, it must undergo rigorous testing from laboratory (phase 
I) to field testing (phase II) (WHO, 2013a). Currently, there are twenty brands of LLINs that are
prequalified by the WHO for use in national distribution campaigns (WHO-PQ, 2018). These 
LLINs are expected to retain their insecticidal activity for at least 3 years (20 washes is used as a 
proxy for 3 years of use), by killing mosquitoes and preventing mosquito bites, to give personal 
and community protection from vector borne diseases (WHO, 2013a). 
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The public health benefit of LLINs is attained through sustained high net access at the community 
level, which is referred to as universal coverage (WHO, 2019). The global target for population 
access to LLINs is ≥ 80%, and is referred to as the minimum operational effectiveness coverage 
level that would translate the impact of LLINs in the community, thus cases and deaths due to 
malaria could be significantly reduced (WHO, 2014a, 2015a). Operationally, this is defined as 
one net used per two people (defacto) in the population (Koenker et al., 2018; WHO/GMP, 2017). 
The governments of endemic countries and international donors, such as Global Fund, President’s 
Malaria Initiative (PMI), as well as non-governmental organisations (NGOs) have been providing 
funds for procurement of LLINs and related logistics to ensure high access to LLINs through 
multiple channels (AMP, 2017). Nevertheless, current access to LLINs is 56% in endemic areas 
(WHO, 2018). Even shortly after mass distribution campaigns of LLINs, population access rarely 
exceeds 80% (Kilian et al., 2017; Koenker, 2018). In Tanzania, access to LLINs is 50% (WHO, 
2018). Insufficient access to LLINs is mainly due to long intervals between net distribution 
campaigns, population growth, inadequate funds and budget limitations on malaria control 
programs (Gomes de Mattos, Oliveira, Leiras, Baptista de Paula Filho & Gonçalves, 2018; 
Khanam et al., 2018; Koenker, 2018; WHO, 2018). Increasing access to LLINs through cost-
effective solutions remains a critical concern and a number of strategies are being explored for 
“keep up campaigns” to retain high LLIN access (WHO/GMP, 2017). 
The logistics involved in mass distribution campaigns are enormous, and were estimated to be 
7% of total costs of LLIN procurement and delivery in Tanzania (Bonner et al., 2011). It is also 
known that the correct storage of nets is important in retaining their bio-efficacy, before and 
during mass distribution campaigns. Exposure of LLINs to direct sunlight (Karakuş et al., 2016) 
and storage at high temperature will degrade the pyrethroid insecticides used on LLINs (Atieli, 
Munga, Ofulla & Vulule, 2010; Karakuş et al., 2016) and guidance on the correct storage 
conditions for LLINs before and during distributions is available (USAID, 2014). However, there 
is limited information on the maximum storage period for LLINs before they are no longer bio-
efficacious.  
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1.2 Statement of the Problem 
Despite various efforts and approaches used in malaria endemic areas to maximize access to 
LLINs, the number of LLINs distributed is not enough due to a number of factors including long 
interval between LLINs distribution campaigns, population growth, inadequate funds and limited 
budget. However, the effective use and appropriate storage of available LLINs is important, 
nevertheless, it is not known how long the LLINs may be stored between distributions. Therefore, 
this study evaluated the bio-efficacy and wash resistance of Olyset® and DawaPlus® 2.0 LLINs 
(rebranded Tsara soft), that had been stored for more than five years (long storage; LS) under 
optimal storage conditions at an average temperature of 29C [25C - 33.4C] and 40% - 100% 
relative humidity (RH). 
1.3 Rationale of the Study  
Maximizing the access (own) and use of LLINs (≥80%), is necessary to translate the communal 
level effect of LLINs through reducing cases and deaths due to malaria. After every three years, 
National Malaria Control Programmes (NMCPs) of endemic countries, conduct mass 
distributions campaigns for universal coverage of LLINs to increase access. Prior to distribution, 
a bulk of nets are stored in facilities, however, it is not known how long the LLINs may be stored 
before distributions. Maintaining optimal storage conditions (Temperature and Humidity) of 
LLINs for continuous distribution of LLINs is necessary to retain their bio-efficacy. Therefore, 
there was a need to understand the bio-efficacy and the period over which the LS nets may be 
stored between distributions, to maximize coverage for sustained malaria control. 
1.4 Objectives 
1.4.1 General objective 
To evaluate the bio-efficacy and wash resistance of long storage Olyset® and DawaPlus® 2.0 
LLINs after five years storage under optimal storage conditions at an average temperature of 29C 
[25C - 33.4C] and 40% - 100% relative humidity. 
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1.4.2 Specific objectives 
(i) To determine the bio-efficacy and wash resistance of LS Olyset® and DawaPlus® 2.0 
LLINs washed 0, 1, 3, 5, 10, 15, and 20 times in the laboratory (Phase I). 
(ii) To determine the bio-efficacy and wash resistance of whole net, LS Olyset® and 
DawaPlus® 2.0 LLINs compared to new unwashed and washed 20 times LLINs of the 
same brands in Ifakara-Ambient Chamber Test.   
1.5 Research questions 
(i) What is the bio-efficacy and wash resistance of LS after five years of storage under 
optimal storage condition? 
(ii) Are there differences in bio-efficacy and wash resistance of long storage when compared 
to new LLINs? 
1.6 Hypothesis 
(i) Null hypothesis (H0): There is no difference in bio-efficacy and wash resistance 
between the new and long storage LLINs against susceptible and resistant mosquito 
strain. 
(ii) Alternative hypothesis (H1): There is a difference in bio-efficacy between the new and 
long storage LLINs against susceptible and resistant mosquito strain. 
1.7    Significance of the study 
The study provide useful information to the NMCPs, other governmental departments of endemic 
areas, International funders, NGOs and other stakeholders involved in malaria control 
programmes on  long-term  storage, storage facilities and  conditions against  LLINs  bio-efficacy 
in order to make informed decision when procuring LLINs. 
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1.8 Delineation of the study 
Several studies have reported on the bio-efficacy, fabric integrity and residue chemical content of 
LLINs under user condition (durability studies). But the current study focused only on evaluating 
the bio-efficacy of LLINs stored for more than five years under optimal storage conditions, 
without domestic use, in order to suggest a cost effective approach for maximizing access of 




2.1 Long- lasting insecticidal nets (LLINs) and their working principles 
Long-lasting insecticidal nets (LLINs) are factory-treated and their insecticides are either 
incorporated into fibres or coated with a binder. They are expected to retain efficacy for three 
years or 20 washes (WHO, 2013a). They work by providing physical barrier between mosquito 
and a person sleeping under. The pyrethroid insecticide and its repellency properties kill and repel 
mosquitoes that come into contact with the LLIN surface. A person sleeping under LLIN is highly 
protected from mosquito bites and where there is a high access of LLINs and use in the malaria 
endemic community, they offer community protection (community level effect of LLINs) 
(Komazawa et al., 2012). Community level effect is a protection of every person in a community 
due to  reduction of population density of malaria vectors by either  being killed by insecticide or 
exhausted during host seeking (Killeen et al., 2011; Komazawa et al., 2012). Quantifying the 
community level effect of LLINs, through mathematical modelling attaining LLINs access of 
>80% to the population at risk of malaria would protect the entire community (Koenker et al., 
2018). 
2.2 Long-lasting insecticidal net delivery approaches in the malaria endemic communities 
 Mass distribution campaigns were recommended by WHO as the main and cost-effective 
delivery approach that  every member of the household has an access to LLIN (Kilian et al., 2017; 
WHO/GMP, 2017). However, several approaches have been also suggested and are used as 
strategy to maximize access to LLINs depending on individual country programs and feasibility. 
These include, routine channels, such as antenatal and child immunization clinics, school and 
community based programs, public sector channel (i.e. voucher scheme), church and mosque, 
agriculture and food supply scheme and work place (WHO/GMP, 2017; WHO, 2013b). These 
channels have increased LLIN accessibility and use in endemic areas (Omonijo, 2019), although 
they are not enough to reach the global targets. Globally, 85% of LLINs were distributed through 
free mass distribution campaigns, 8% in antenatal (ANC) care facilities and 4% as part of 
immunization programs (EPI) (WHO, 2018). Kramer et al. (2017) in Tanzania and Raghavendra 
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et al. (2017) in India reported that, the use of Tanzania National Voucher Scheme (TNVS), was 
highly innovative approach that promoted  effective and equitable distributing of LLINs for 
protection of the population at risk of malaria (Kramer et al., 2017; Raghavendra et al., 2017). 
However, the TNVS  was abolished due to fraud and corruption in 2014 (RBM, 2016). 
2.3 Availability of LLINs in malaria endemic countries 
To ensure sustainable availability of LLINs in malaria endemic areas, NMCPs with the support from 
WHO have been using several initiatives for the benefits of people at risk of malaria. International 
donors and governments of the endemic areas have been great funders of LLINs (WHO, 2018). 
United States Agency for International Development (USAID/PMI) (Krezanoski, 2016), Global fund, 
World Bank and NGOs i.e. Bill and Melinda Gates Foundation are the giant funders for LLINs 
worldwide  (Hoibak, 2019; Krezanoski, 2016; WHO, 2018). According to the WHO report in 2018, 
624 million of LLINs were delivered globally in 2017. About 552 million LLINs were distributed 
by NMCPs, 459 million (83%) of LLINs were delivered in sub-Saharan Africa over the period 
2015–2017 (WHO, 2018). 
2.4 Resistance of mosquitoes to the effectiveness of LLINs 
Pyrethroid is the only class of insecticides recommended by WHO for use on bed nets, due to low 
human toxicity and effective insecticidal functions for killing and preventing mosquito bites 
(Ranson et al., 2011). The pyrethroid insecticides have been used for a long period of time for 
malaria vectors control and agricultural activities (Mahande, Msangi, Lyaruu & Kweka, 2018; 
Matiya, Philbert, Kidima & Matowo, 2019). Frequent use of pyrethroids have led the mosquitoes 
to develop  resistance mechanism  (Matiya et al., 2019). Insecticide resistance refers to the ability 
of an insect to tolerate or adapt the adverse effects and toxicity of an insecticide by means of 
natural selection or mutations (Ranson et al., 2011; Silva, Santos & Martins, 2014) through 
diverse mechanisms such as metabolic resistance (over-expression of cytochrome P450 genes) 
and knockdown (Kdr) resistance (Kisinza et al., 2017; Ranson et al., 2011; Silva et al., 2014).  
The insecticide resistance is widely prevalent  in Africa (Churcher, Lissenden, Griffin, Worrall & 
Ranson, 2016; Toto, Adam, Peter & Lines, 2017), including Tanzania (Kabula, 2014; Kisinza et 
al., 2017).  Managing pyrethroid resistance and improving the performance of LLINs in areas 
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with insecticide resistant vectors, new generation of LLINs with active ingredients synergistically 
(pyrethroid insecticide and Piperonyl-butoxide (PBO)) have been developed.  It has been  proved 
that, PBO-LLINs are more effective towards pyrethroid resistant mosquitoes resulting in a 60% 
reduction in malaria parasite prevalence among users (Protopopoff et al., 2018). Piperonyl-
butoxide(PBO) is a biochemical substance that hinders (P450 inhibitor) enzymatic responses of
insects against detoxifying pyrethroid for its survival, hence reinstate the killing effect of 
pyrethroid (Gleave, Lissenden, Richardson & Ranson, 2017; Protopopoff et al., 2018).  
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CHAPTER THREE 
MATERIALS AND METHODS 
3.1 Study design 
Two brands of LLINs: Olyset® and DawaPlus® 2.0 that had been stored for more than five years, 
denoted as long storage (LS) LLINs under recommended conditions, were evaluated. The study 
was conducted in two stages. First, through  randomized double blinded, bio-efficacy evaluation 
of LLINs using standard WHO assays (WHO, 2013a). This was followed by a partially 
randomized double blinded semi field tests to compare the bio-efficacy of LS LLINs  to new 
LLINs of the same brand using the Ifakara Ambient Chamber tests (I-ACT) (Massue et al., 2019). 
Un-treated Safi Net was used as a negative control in all tests to monitor the quality of the 
experiment.  
3.2 Test facility 
The experiments were performed at the Vector Control Product Testing Unit (VCPTU) of the 
Ifakara Health Institute located in Bagamoyo, Tanzania (http://ihi.or.tz/static/media/Vector-
Control-Product-Testing.e31c173f.pdf). 
3.3 Test nets 
Olyset® is a high-density mono-filament polyethylene (HPDE) LLIN, incorporated with 20 g/kg 
(±3 g/kg), 2% w/w of permethrin (corresponding to 1000 mg/m2). Olyset® is manufactured by A 
to Z Textile Mills Ltd, Arusha, Tanzania. DawaPlus® 2.0 LLIN name was changed to Tsara® soft. 
Tsara soft is a deltamethrin-coated on a knitted multi-filament polyester fiber with target dose of 
2.0 g/kg ± 25% with 100-denier yarn (corresponding to 80 mg/m2). It is manufactured by NRS 
Moon Netting FZE Pakistan. Safi Net is untreated net made of polyester fibres, manufactured by 
A to Z Textile Mills Ltd, Arusha, Tanzania. The net was used to control the quality of the 
experiments. All nets used in this study were double sized and coded by an independent 
technician, to allow blinding of investigators and participants. All test nets have WHO-PQ listing. 
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3.4 Net Storage conditions 
Long storage Olyset® and DawaPlus® 2.0 LLINs were stored at the Ifakara Health Institute (IHI-
Bagamoyo) storage facility. All nets were received directly under similar conditions from the 
manufacturer and were manufactured shortly before shipping for the purpose of product 
evaluation. Long storage Olyset® LLINs with batch number L2605 were manufactured in May, 
2013 and logged into the IHI-Bagamoyo storage facility on 4th June, 2013. Long storage 
DawaPlus® 2.0 LLINs were regular production manufactured in November, 2013 and were 
logged into the IHI-Bagamoyo storage facility on 4th December, 2013. 
The new Olyset® LLINs were manufactured in 2017 with batch number 7X15BZS, and were 
logged into the IHI-Bagamoyo storage facility on 22nd December, 2018. The new DawaPlus® 2.0
LLINs were test series manufactured on March, 2018, with batch number 18SPL005, and were 
shipped from the manufacturer on 15th May, 2018 and logged into the IHI-Bagamoyo storage 
facility on 1st June, 2018. All nets were stored and maintained at an average temperature of 29C 
[25C - 33.4C] and 40% - 100% relative humidity in the IHI-Bagamoyo storage facility. 
Temperature was recorded and logged each afternoon at 1400 h which coincides with peak 
temperatures.  
The experiments were conducted from 25th January 2019 to July 2019. Olyset® LLINs had been 
stored for 5 years and 2 months while DawaPlus® 2.0 LLINs had been stored for 4 years and 8 
months at the time of WHO cone assays and tunnel testing. Olyset® LLINs had been stored for 5 
years and 8 months while DawaPlus® 2.0 LLINs had been stored for 5 years and 2 months at the 
time of I-ACT testing. 
3.5 Net preparation for WHO bio-assays 
Eight LLINs (4 nets of each brand) were selected at random from their product batches. LLINs 
were coded, cut into pieces (25 cm x 25 cm) and washed at 1, 3, 5, 10, 15, 20, and 25 times  
following WHO standards procedures for phase I (WHO, 2013a). One day washing interval was 
used based on the reported regeneration time for both products (WHO, 2009). 
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3.6 Net pieces cutting procedures for WHO cone bio-assay 
Four of each Olyset® and DawaPlus® 2.0. Thirty-six pieces of 25 cm by 25 cm were cut from 
Olyset®  (nine pieces from each whole net) and equivalent number of pieces were also cut from 
DawaPlus® 2.0  (nine from each whole net) wrapped in aluminum foil and held at 2-8oC and 
stored subsequent to  WHO procedures and guidelines (WHO, 2013a). Eight pieces (8) were 
randomly selected from Olyset® LLINs (two pieces from each net) and equivalent number of net 
pieces were also randomly selected from DawaPlus® 2.0 LLINs (two from each net) for 
regeneration time evaluation.  The regeneration time of both Olyset® and DawaPlus® 2.0 LLINs 
was known to be one day (WHO, 2009), therefore, regeneration time evaluation  was not 
conducted in this study. For wash resistance evaluation, 28 pieces were randomly selected from 
each Olyset® (7 pieces randomly selected from each net) and equivalent number was also 
randomly selected in DawaPlus® 2.0   LNs (7 pieces from each net).   
Figure 1: Net piece cutting process and storage 
Key:  
 a = Net pieces cutting process type one    
b = Net pieces cutting process type two and 
c = Net pieces storage after cutting. 
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3.6 Washing procedures for WHO bio-assay 
Washing removes insecticides from the surface of LLIN, but regenerates after few hours and this 
is known as regeneration time. Regeneration time is a time taken by LLIN to recover the 
insecticides after wash. This was done to test the wash resistance of the nets.  Net samples; LS 
Olyset® (28 pieces) and LS DawaPlus® 2.0 (28 pieces) were washed in the laboratory following 
WHO standards and guideline (WHO, 2013a). Each net sample was individually introduced into 
1-litre glass bottles containing 0.5 litre deionized water, with 2.5 ml of the stock Collaborative 
International Pesticide Analytical Council washing agent (CIPAC), and the bottle was capped 
with a steel lid and inverted 10 times. The bottle was then placed in a water bath in an upright 
position for 10 minutes (Fig. 2a), after which the piece of netting was removed with tweezers 
and excess fluid removed by gently shaking. After washing, the piece of netting was added to a 
1 litre glass bottle containing 500 ml of de-ionized water at 30°C ± 5°C. The bottle was capped 
with a steel lid, inverted 10 times and the placed in a water bath in an upright position for 10 
minutes again. After 10 minutes, the net sample was removed using tweezers. This procedure 
was repeated for third time, and then after the second rinse, the net sample was gently shaken to 
remove excess water and then allowed to dry on a line for 30 minutes at room temperature (27°C 
± 5) out of direct sunlight (Fig. 2b). Once dry, the net samples are wrapped in aluminium foil 
and stored at 30°C in the incubator until the next wash. 
Figure 2: Net pieces washing process in the laboratory 
Key: 
       a = Technician washing individual net pieces in a 1 L bottle and b = Technician lining net 
pieces after wash. 
13 
3.7 Net preparation for I-ACT assays 
Eight LLINs (2 old and 2 new DawaPlus® 2.0 and 2 old and 2 new Olyset®) and 2- untreated Safi 
nets were randomly selected from their product batches and coded. Two LLINs of each brand 
were washed 20 times as per WHO phase II washing procedures as a standard procedure to 
simulate aging of nets under user conditions (WHO, 2013a), while the other two were unwashed. 
All washed, unwashed and un-treated Safi nets were deliberately holed 6 times with 4 cm by 4 
cm with one hole on each width and two holes on each length side, 75 cm from the top of the net 
(half way) as per WHO procedures (WHO, 2013a). 
3.8 Net washing procedures for semi-field testing (I-ACT) 
Each net was independently washed in an aluminium bowl containing 10 L of IHI bore well water 
and 20 g dissolved of JAMAA soap (2 g/litre). Each net was washed, by stirring it using heavy 
duty gloved hand for 3 minutes at 20 rotations per minute (r/min). After that a net was left to soak 
for 4 minutes. Then the net was removed from the bowl after 4 minutes and hung over a line, and 
the bowl was emptied. Another 10 L of fresh water was added in the bowl and the net was added 
and stirred for 2 minutes at 20 r/min, followed then by removal from the bowl and hang over the 
nylon line for the second time. After emptying the bowl, another 10 L of fresh water was added 
and the net was put back and stirred for 2 minutes at 20 r/min. Finally, the net was lined for drying 
in a shade. The net was then repacked in the foil after drying, labeled and stored at 27+/-2 until 
next wash. Each net was washed once per day, for 20 days consecutively. Then the nets were 
holed deliberately before the experiments as explained at section 3.7 above, shown in (Fig. 3) 
below. 
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Figure 3: Phase two net washing process 
Key: 
       a = Technicians washing whole net and b = Technicians drying of whole net under shade   
3.9.1 Test systems 
The study used Anopheles gambiae (Ifakara strain) fully susceptible to all classes of insecticides 
and Anopheles arabiensis (Kingani strain) resistant to all pyrethroids, including deltamethrin and 
permethrin (<20% mortality with WHO discriminating doses, metabolic CYP450 mechanism). 
Three to five days old female sugar fed mosquitos were used in cone bioassays, while 5-8 days 
old female sugar starved mosquitos were used in the tunnel test and I-ACT. The VCPTU mosquito 
colonies were maintained at 27°C ± 5 and 40% - 100% relative humidity, with access to 10% 
sucrose ad libitum supplemented by membrane feeding using cow blood for the purposes of egg 
laying following MR4 guidelines (Kaufmann, 2014). 
3.9.2 World Health Organization Bio-assay 
(i) Cone bioassay procedures 
The standard WHO cone bioassay was used to determine the bio-efficacy and wash resistance of 
long stored LLINs: Olyset® and DawaPlus® 2.0. On each net sample standard WHO cone was 
placed and held in place using a plastic manifold. This was conducted to the unwashed and 
washed for 1, 3, 5, 10, 15, 20, and 25 times at one-day intervals. Five laboratory-bred susceptible 
An. gambiae s.s (Ifakara strain) mosquitoes, sugar fed of 3-5 day old were put into each cone and 
exposed for 3 minutes. The procedure was repeated to resistant An. arabiensis (Kingani strain) 
strongly resistant to deltamethrin (<20% mortality) following WHO guideline (WHO, 2013a). 
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After the exposure, mosquitoes were removed gently from the cones and kept separately in paper 
cups using siphon and provided with cotton wool moistened with 10% sucrose solution. The 
Outcome measurement were the proportion of mosquitoes Knockdown after 60 minutes (KD60) 
and mortality after 24-hr (Table 1). Long storage LLINs that failed to meet WHO efficacy criteria 
(i.e. ≥95% KD60 and ≥80% 24-hr mortality) in the standard WHO cone bioassay were subjected 
to WHO tunnel test (WHO, 2013a) (Table 1, Fig. 4). Each test replicate and associated control 
was tested with both the susceptible and resistant strain.  
Figure 4: Cone bio-assay procedures 
Key: 
    A = Schematic diagram of WHO cone bio-assays  
    B = Standard cone placed on net piece  
    C = Releasing mosquitoes in each cone for 3 minutes exposure on each net type. 
(ii) WHO Tunnel test procedures. 
WHO Tunnel test was used to assess blood-feeding inhibition through comparing the proportion 
of blood-fed females (alive or dead) in treatment and control tunnels. Overall mortality was 
measured by pooling the mortalities of mosquitoes from the two sections of the tunnel. Both 
unwashed and washed. Only one of the four net pieces, which gave mortality closest to the 
average mortality in the cone bioassay was selected. At 1800 h, in each WHO tunnel, one hundred 
mosquitoes were released per tunnel. Each piece was tested with both the susceptible and resistant 
strains on separate occasions. A control for each of the strain was used (WHO, 2013a) (Table 1). 
The mode and  structure of the WHO tunnel was followed as per WHO guideline and as explained 
by other authors (Massue et al., 2019; WHO, 2013a). A restrained rabbit bait unable to move was 
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introduced in the cage at the end of the longer section of the tunnel. The next morning at 0900 h 
mosquitoes were removed using a mouth aspirator and counted separately from each section of 
the tunnel.  Blood feeding inhibition and 24-hr mortality were the outcome measures (Table 1, 
Fig. 5). 
Figure 5: Tunnel test process 
Key: 
a = Schematic diagram of WHO tunnel with rabbit as a bait and b = Technicians setting up 
WHO tunnel test experiment. 
3.9.3 Ifakara Ambient Chamber Test assay 
I-ACT was used as an intermediate between laboratory and experimental hut tests (Massue et al., 
2019). One LLIN per condition (unwashed or 20 times washed) was tested. Each LLIN and 
control was randomly assigned to one of the ten testing chambers of the I-ACT (Fig. 1a). At 2100 
h, 30 An. gambiae and 30 An. arabiensis, were released in each testing chamber. Mosquitoes were 
lightly dusted with fluorescent powder (SWADA, Cheshire, United Kingdom) to distinguish the 
strain as they are morphologically identical. At 0630 h, mosquitoes were collected into paper cups 
using a mouth aspirator. Mosquitoes were scored immediately after collection by strain and four 
categories: a) dead and unfed, b) dead and blood-fed, c) alive and unfed or d) alive and blood-
fed. Mosquitoes were then held in the testing laboratory at 27°C ± 5 and 40% - 100% relative 
humidity with 10% sugar solution. After 24-hr, the proportion of mosquitoes in each of the four 
categories was again scored. After each experiment, test nets were re-packed in their respective 
bags, chambers were cleaned and bed sheets were washed. Long-lasting insecticidal nets 
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remained fixed to their respective chambers while volunteers rotated nightly between chambers, 
for ten experimental nights so that each volunteer tested each net type once. This was done to 
account for difference between human attractiveness to mosquitoes that might affect the 
proportion of mosquito’s blood feeding. Acceptable control mortality was ≤ 10% or ≥50% blood-
feeding success (WHO, 2013a) (Table 1, Fig. 6). 
Figure 6:Semi-field system (I-ACT) 
Key: 
     A = Schematic diagram of the Ifakara Ambient Chamber Test (I-ACT with10 chambers) 
    B = I-ACT at IHI-Bagamoyo branch  
    C= Volunteer releasing mosquito within chamber outside the net; 
    D= Volunteer sleeping in side net within a chamber; 
    E= Volunteer collecting mosquitoes using mouth aspirator (siphon) inside net within chamber. 
    F= Volunteer collecting mosquitoes using siphon outside net within chamber.  
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Table 1: Summary of experimental design on WHO and I-ACT Bioassays 
















80  per net 
3 minutes 
27°C ± 5°C  
40% - 100% RH 
3-5 days female 
Nulliparous, sugar fed 
None 
% KD60  
% 24-hr mortality 
≥95%  KD60  
≥80%  24-hr mortality 
≤10% mortality 
Descriptive analysis 
100 per net piece 
12 hours 
27°C ± 5°C  
40% - 100% RH 
5-8 days female, sugar 
starved, nulliparous 
Rabbit 
% Feeding inhibition 
 % 24-hr mortality 
≥90% Feeding inhibition 
≥80% 24-hr mortality     
≥50% feeding success 
≤10% mortality 
Descriptive analysis 
60 (30 per strain) per net 
9 hours 
27°C ± 5°C     
40% - 100%  RH 
5-8 days female, sugar starved, 
nulliparous 
Human 
% Feeding inhibition 
 % 24-hr mortality 
≥90% Feeding inhibition 
≥80% 24-hr mortality     
 ≥50% feeding success 
≤10% mortality 
Descriptive analysis & 
Binary logistic regression 
3.9.4 Data management and analysis 
Data were recorded on paper forms, double entered into Microsoft excel 2013 and cleaned prior 
to analysis. Data analysis was performed using STATA 13.1. Descriptive statistics were used for 
WHO cone and tunnel tests. For I-ACT, both descriptive statistics and mixed effect binary logistic 
regression were conducted. The outcome measures were 24-hr mortality and blood feeding 
inhibition.  Model fit was tested using AIC (Shi & Tsai, 2002). For the model with mortality as 
the outcome, the best fitting model had treatment and volunteer as fixed effect and day as a 
random effect while best model with feeding success as the outcome had treatment as a fixed 
effect, with both volunteer and day as random effects. 
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3.9.5 Ethical approval and volunteer’s protection 
Ethical approval was granted by National Institute of Medical research (NIMR/HQ/R. 8a/VIX 
/115 and Institutional Review Board of the Ifakara Health Institute (IHI/IRB/No: 19-2013 and 
IHI/IRB/No: 04 - 2019). Human volunteers for net washing and I-ACT were recruited upon a 
written informed consent that explained the purpose and procedures of the study as well as their 
roles. Compensation was provided to sleeping volunteers for their time away from home and all 




RESULTS AND DISCUSSION 
4.1 Results 
4.2 World Health Organization assays results against susceptible An. gambiae s.s 
Long storage Olyset® LLIN stored for 5 years and 2 months (long storage, LS) fulfilled WHO 
bio-efficacy criteria up to 20 washes based on the combined WHO Cone bioassay and tunnel test 
against susceptible An. gambiae s.s. (Table 2). Long storage Olyset® LLIN, demonstrated 95% 
KD60 up to 10 washes in cone bioassay (Fig. 7a) and >90% feeding inhibition up to 20 washes 
in tunnel tests (Fig. 2d). Mortality was low in cone bioassays (Fig. 7b).  
Long storage DawaPlus® 2.0 LLIN stored for 4 years and 8 months fulfilled WHO bio-efficacy 
criteria up to 20 washes based on cone bioassay against susceptible An. gambiae s.s. (Table 2). 
Long storage DawaPlus® 2.0 LLIN, demonstrated 100% KD60 up to 20 washes (Fig. 7a) and 
>90% 24-hr mortality up to 20 washes (Fig. 7b).  
4.2 World Health Organization assays results against resistant An. arabiensis  
Long storage Olyset® LLIN did not fulfil WHO efficacy criteria up to 20 washes based on the 
combined WHO Cone bioassay and tunnel test against resistant An. arabiensis (Table 2). Long 
storage Olyset® LLIN did not approach the 95% KD60 threshold in cone tests, as well as >80% 
24-hr mortality (Fig. 8a and Fig. 8c). In the tunnel tests, LS Olyset® LLIN did not approach the 
90% feeding inhibition in all tests, except nets washed 3 and 15 times demonstrated >90% feeding 
inhibition (Fig. 8d). Long storage Olyset® did not generate 80% 24-hr mortality up to 20 washes 
in both cone and tunnel tests (Fig. 8c). 
Long storage DawaPlus® 2.0 LLIN fulfilled WHO bio-efficacy criteria up to 20 washes based on 
the combined WHO Cone bioassay and tunnel test against resistant An. arabiensis (Table 2). Long 
storage DawaPlus® 2.0 LLIN, either demonstrated >95% KD60 (Fig. 7a) in cone bioassay or 
>90% feeding inhibition (Fig. 8d). It did not demonstrate 80% 24-hr mortality up to 20 washes in 
both cone and tunnel tests (Fig. 8c). 
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Table 2: World Health Organization bio-assays results against Anopheles mosquito strains 
N= number of mosquitoes released on each test
Test system Test item Washes 
Cone test 
(N= 80) 
































96.25 [95.06 – 97.44] 
93.75 [89.24 – 98.26] 
93.75 [92.56 – 94.94] 
83.75 [79.68 – 87.82] 












































92.50  [90.12-94.88] 
100 





































38.75 [34.68 - 42.82] 
25.00 [19.85 - 30.15] 
23.75 [19.68 - 27.82] 
51.25 [47.18 - 55.32] 
36.25 [33.25 - 39.25] 
53.75 [40.79 - 66.71] 
58.75 [57.56 - 59.94] 
0 
01.25 [00.06 - 2.44] 
03.75 [01.47 - 6.03] 
03.75 [02.56 - 4.94] 
































50.00 [44.85 - 55.15] 
63.75 [61.47 - 66.03] 
67.50 [63.37 - 71.63] 
91.25 [87.68 - 94.82] 
100 
97.50 [96.12 - 98.88] 































4.3 Ifakara Ambient Chamber Test results against Susceptible An. gambiae s.s  
Unwashed and 20 times washed LS Olyset® and DawaPlus® 2.0 against susceptible An. gambiae 
s.s, exceeded the WHO bio-efficacy criteria for tunnel test on 24-hr mortality (≥ 80%) and feeding 
inhibition (≥90%). Unwashed and 20 times washed LS Olyset® and LS DawaPlus® 2.0 nets 
performed similar to new nets of the same brand and washing status, showing almost identical 
measurements of mortality and feeding inhibition (Table 3). Washing the nets 20 times only 
marginally reduced their efficacy but still induced high mortality and feeding inhibition, with the 
old nets nearly as efficacious as the new nets. On the mortality endpoint, LS unwashed Olyset® 
marginally outperformed the new unwashed Olyset®: 99.30% [98.25 - 100] vs 96.28% [93.64 – 
98.93], Odds ratio 0.17 [0.04 – 0.79] p=0.024. On the feeding inhibition endpoint, LS DawaPlus® 
2.0 20x washed marginally outperformed the new DawaPlus® 2.0 20 times washed: 95.62% [92.81 
– 98.42] vs 83.81% [78.98 – 88.64] OR 4.37 [2.67 – 7.15], p<0.0001.  
4.4 Ifakara Ambient Chamber Test results against Resistant An. arabiensis  
Unwashed LS Olyset® and unwashed LS DawaPlus® 2.0 against resistant An. arabiensis, exceeded 
the WHO bio-efficacy criteria for tunnel tests on feeding inhibition (≥90%). All the net types and 
condition failed to meet WHO bioefficacy criteria on 24-hr mortality (≥ 80%) against the resistant 
strain. Unwashed and 20x washed Olyset® and DawaPlus® 2.0 LS nets performed in a similar way 
to new nets of the same brand and washing status on both endpoints showing almost identical 
mortality and feeding inhibition (Table 3). As was observed with the susceptible strain, on the 
mortality endpoint, LS unwashed Olyset® marginally outperformed the new unwashed  Olyset® 
63.40% [47.83 - 78.97] vs 50.31% [33.42 - 67.19], Odds ratio 0.49 [95% CI: 0.33 – 0.72], 
p<0.0001. On the feeding inhibition endpoint, LS unwashed DawaPlus® 2.0 marginally 
outperformed the new unwashed Tsara® Soft: 91.57% [88.72 - 94.41] vs 81.78% [75.49 - 88.07], 
OR 2.55 [1.61 – 4.06], p<0.0001. Additionally, on the feeding inhibition endpoint, LS 20 times 
washed DawaPlus® 2.0 outperformed the new 20 times washed DawaPlus® 2.0: 83.28% [76.48 - 
90.08] vs 59.87% [49.89 - 69.85], OR 4.07 [2.60 – 6.36], p<0.0001. 
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Table 3: Ifakara Ambient Chamber Test results against mosquito strains 




Odds of dying 
[95 % CI] 
p- value 
 
% Feeding Inhibition§  
[95% CI] 
Odds of Feeding 








LSª Olyset® unwashed 
New Olyset® unwashed 
 
LS Olyset® washed 
New Olyset® washed 
 
Old DawaPlus® 2.0 unwashed 
New DawaPlus® 2.0 unwashed 
 
Old DawaPlus® 2.0 washed 
New DawaPlus® 2.0 washed 
99.30 [98.25 – 100.0] 
96.28 [93.64 – 98.93] 
 
85.73 [76.58 – 94.86] 
85.44 [74.29 – 96.59] 
 
99.66 [98.88 – 100.0] 
99.65 [98.88 – 100.0] 
 
100 
96.94 [95.56 – 98.32] 
1.00 
0.17 [0.04 – 0.79] 
 
1.00 


















94.00 [92.76 - 99.11] 
97.27 [94.84 – 99.69] 
 
91.40 [88.66 – 94.14] 
92.29 [88.73 – 95.86] 
 
96.12 [94.40 – 97.83] 
89.37 [82.90 – 95.84] 
 
95.62 [92.81 – 98.42] 
83.81 [78.98 – 88.64] 
1.00 
0.54 [0.05 – 5.80] 
 
1.00 
0.84 [0.35 – 1.99] 
 
1.00 
2.14 [0.62 – 7.47] 
 
1.00 



















Old Olyset® unwashed 
New Olyset® unwashed 
 
Old Olyset®  washed 
New Olyset® washed 
 
Old DawaPlus® 2.0 unwashed 
New DawaPlus® 2.0 unwashed 
 
Old DawaPlus® 2.0 washed 
New DawaPlus® 2.0 washed 
 
63.40 [47.83 - 78.97] 
50.31 [33.42 - 67.19] 
 
33.34 [17.91 - 48.77] 
37.85 [20.11 - 55.59] 
 
71.30 [56.28 - 86.32] 
68.91 [50.64 - 87.19] 
 
48.73 [34.18 - 63.28] 
45.74 [27.90 - 63.57] 
 
1.00 
0.49 [0.33 – 0.72] 
 
1.00 
1.18 [0.81 - 1.72] 
 
1.00 
0.82 [0.53 – 1.3] 
 
1.00 














92.10 [88.24 - 95.95] 
95.16 [91.07 - 99.26] 
 
84.25 [79.51 - 88.99] 
86.88 [80.34 - 93.43] 
 
91.57 [88.72 - 94.41] 
81.78 [75.49 - 88.07] 
 
83.28 [76.48 - 90.08] 
59.87 [49.89 - 69.85] 
 
1.00 
0.37 [0.08 – 1.76] 
 
1.00 
0.67 [0.29 – 1.51] 
 
1.00 
2.55 [1.61 – 4.06] 
 
1.00 













N= 30 mosquitoes released per strain per test; *Arithmetic mean control corrected mortality with 95% confidence interval (CI) § 
Arithmetic mean feeding inhibition with 95% confidence interval (CI); ªLS= long storage 
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Figure 7: World Health Organization bio-assay results against susceptible An. gambiae 
s.s
Key: 
    (a) % KD60,   (b) WHO cone assay % 24-hr mortality,  (c) Tunnel test % 24-hr mortality 
and  
    (d) % Feeding inhibition. 
In all graphs (a, b, c and d) the dashed line is the WHO cut off criteria, 95% for KD60, 80% for 
mortality, and 90% for blood-feeding inhibition 
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Figure 8: World Health Organization bio-assay results against resistant An. arabiensis  
Key: 
      (a) % KD60,   (b) WHO cone assay % 24-h mortality,   (c) Tunnel test % 24-hr mortality 
and 
     (d) % Feeding inhibition.  
 
In all graphs (a, b, c and d) the dashed line is the WHO cut off criteria, 95% for KD60, 80% for 




(i) Storage conditions of LLINs and Implications to Malaria control programmes 
This study provides valuable information on the effect of long storage conditions on the bio-
efficacy of LLINs for malaria control programs. The study showed that LLINs remained 
efficacious despite being stored for more than five years under controlled storage conditions. 
The nets used for this study were pyrethroid of two types: Olyset®, a permethrin incorporated 
net, and DawaPlus® 2.0, a deltamethrin coated net with insecticide held to the filaments using 
a binder.  
It was necessary to keep the investigational LLINs under ideal temperature and humidity 
conditions, as known, high temperature may inactivate the insecticide or binder (Karakuş et al., 
2016; Peck et al., 2014). Proper storage should also avoid direct sunlight as pyrethroids are 
decomposed by UV light and heat (WHO, 2015b). Several studies have been conducted to 
evaluate the storage conditions for LLINs for instance, in Turkey by Karakus et al. (2016) 
reported that nets exposed to direct sunlight for six months had lower efficacy (44.4% 24-hr 
mortality), than other groups of nets which were not exposed to sunlight (100% 24-hr mortality) 
(Karakuş et al., 2016). Atieli et al. (2010) showed that drying methods used after washing nets, 
resulted in significant impact on the efficacy of pyrethroid nets: nets washed 20 times and dried 
under the shade retained more pyrethroid insecticide (62.5%) than nets directly dried under the 
sunlight (58.8%) (Atieli et al., 2010). Furthermore, Peck et al. (2014) reported that the 
insecticidal activity of the pyrethroid Lambda-cyhalothrin was reduced after 10 weeks of 
exposure to direct sunlight (Peck et al., 2014).  
LLINs are designed to withstand high temperatures that may be encountered in the tropics and 
the findings from this study suggest that nets can retain bio-efficacy for up to five years if stored 
out of sunlight at the range of 25C to 33.4C and 40% - 100% relative humidity. The storage 
conditions used in this study aligned with the manufacturer specification and WHO guidelines 
(WHO, 2014b, 2015b). It should be noted that the LLIN store used for this study was a shipping 
container (Fig. 9) that uses only passive cooling for the majority of the year. The container is 
raised above the ground and is situated under a second shade roof to reduce the radiant transfer 
of heat. It is also equipped with ventilation gaps (similar to the eaves of African houses) to allow 
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air movement through the store. Electric ceiling fans are used only at the hottest times of the 
year irrespective of the temperature. Therefore, investment in similar storage facility of the 
Ifakara Health Institute for LLINs can ensure longevity efficacy of LLINs at a low running cost. 
Also National malaria programmes and other stakeholders should be well informed on the 
appropriate long-term storage conditions for pyrethroid nets in order for the LLINs to retain 
their bio-efficacy, if nets are to be stored for extended period before distribution.   
 
Figure 9: The Bagamoyo IHI LLIN storage facility 
(ii) Performance of LLINs against Test system and Washes in the WHO bio-assays 
The performance of long storage (LS) LLINs varied between net brands and washes in the WHO 
cone bioassay. DawaPlus® 2.0 LLIN, met the WHO criteria in the standard WHO cone assay 
without the need to conduct a WHO tunnel test, while Olyset® LLIN failed to meet the criteria 
based on the cone assay but passed based on WHO tunnel test (Table 2) due to (a) Olyset® is a 
high density polyethylene, permethrin moves slowly with short wash intervals, hence very low 
surface concentrations, sufficient to induce KD60 effect,  but insufficient to mortality (b) the 
irritant action of the permethrin insecticide incorporated in Olyset® (Massue et al., 2019; 
Rafinejad et al., 2008). This mode of action reduces the probability of mosquito dying from 
exposure to the insecticide following multiple contacts with net, but also gives Olyset® its 
feeding inhibition properties that were observed in the I-ACT, allowing protection of human 
volunteers sleeping beneath them even after 5 years and 2 months of storage. Similar results 
were observed by Massue et al. (2019). It was again observed, by Jaramillo et al. (2011), on 
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which permethrin treated net (Olyset® LLIN) reduced contacts of An. albimanus to net surface 
in the cone test (Jaramillo, Robledo, Mina, Muñoz & Ocampo, 2011).  
Both LS Olyset® and DawaPlus® 2.0 failed to meet the WHO mortality efficacy criteria (≥ 80%) 
against the resistant An. arabiensis (Kingani strain), but the nets still performed well on the 
feeding inhibition end points. As the candidate LLINs utilize pyrethroid insecticides, it is 
expected  the nets to show reduced efficacy against pyrethroid resistant populations, however, 
it is clear that LLIN performance was not significantly impaired as a result of long storage, but 
due to ability of the resistant strain to detoxify pyrethroids (Alemayehu et al., 2017; Kisinza et 
al., 2017; WHO/ GMP, 2016). It is for this reason that piperonyl butoxide-treated insecticidal 
nets (PBO) nets have been developed (Protopopoff et al., 2018). The PBO is a synergist 
biochemical substance, combined with pyrethroid, that hinder enzymatic responses of insects 
against detoxifying pyrethroid for its survival, and allow the pyrethroids insecticide to finally 
kills pyrethroid resistant mosquitoes (Gleave, Lissenden, Richardson, Choi & Ranson, 2018). 
Although, it is interesting that both nets still performed well on the feeding inhibition end point, 
which means that LS-LLINs can still confer protection, therefore reiterate the usefulness in the 
continuous control of mosquitoes. 
(iii) Performance of LLINs against Test system and Washes in the I-ACT 
Results from the I-ACT with volunteers sleeping beneath the LLINs complemented the 
evidence provided by the WHO cone assays and allowed for comparison between new nets and 
long storage nets of the same brand and washing status. Using WHO pass/fail thresholds, 
findings from WHO cone assays and the I-ACT with LS nets agreed between net brands and 
washes. Although, using the WHO criteria, both LS nets and new nets passed with the 
susceptible strain but inconsistent with the resistant strain in the IACT. Ifakara Ambient 
Chamber Test (I-ACT), demonstrated higher feeding inhibition and mortality (Table 2, Table 
3), than the results obtained in WHO bio-assays. The increased performance of LLINs in the I-
ACT might be due to (a) extended exposure time that increased number of contacts between 
mosquitoes and the LLIN, (b) use of a whole net, (c) use of a preferred (human) bait by mosquito 
and (d) larger surface are of net presented to the mosquitoes. Similar I-ACT results have also 
been observed by Massue et al.  (2019). However, it should be understood from our findings 
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that, long storage nets performed similarly to the new nets in the I-ACT on both mortality and 




CONCLUSION AND RECOMMENDATIONS 
5. 1 Conclusion 
Even after long-term storage of around 5 years, Olyset® and DawaPlus® 2.0 LLINs remained 
efficacious against susceptible Anopheles mosquitoes at optimal storage range of 25C - 33.4C 
for temperature and 40% - 100% relative humidity measured by standard WHO methods. Also, 
DawaPlus® 2.0 currently known Tsara® soft passed WHO efficacy criteria on unwashed LLINs 
and after 20 washes against resistant An. arabiensis. These data were confirmed in the I-ACT. 
Therefore, long stored nets can still be useful in controlling malaria in endemic areas. 
5.2 Recommendations 
This study was conducted as per protocol subsequent to WHO guideline on LLINs evaluation. 
Therefore, based on the findings obtained in this study, I recommend the following.  
(i) Long storage of LLINs at optimal storage conditions at the range of 25C - 33.4C for 
temperature and 40% - 100% RH, does not affect the bio-efficacy of LLINs against 
Anopheles mosquitoes for more than five years.  
(ii) Storage condition for LLINs are very important for Programmes in malaria control. 
(iii) Provided nets are stored well, they can be stored for use in continuous distribution 
campaigns to maximize LLINs coverage for sustained malaria control in endemic areas. 
(iv) There is a need to evaluate inter-net heterogeneity, proxy for aging and damage (fabric 
integrity) as well as the bursting strength of long storage nets. It is important as heat may 
damage net fibres. 
(v) There is a need to evaluate the long storage nets in different storage conditions apart from 






Agossa, F. R., Padonou, G. G., Fassinou, A. J. Y. H., Odjo, E. M., Akuoko, O. K., Salako, A., 
… Akogbeto, M. C. (2018). Small ‑ scale field evaluation of the efficacy and residual 
effect of - Fludora® Fusion ( mixture of clothianidin and deltamethrin ) against 
susceptible and resistant Anopheles gambiae populations from Benin, West Africa. 
Malaria Journal, 1–10. https://doi.org/10.1186/s12936-018-2633-6 
Alemayehu, E., Asale, A., Eba, K., Getahun, K., Tushune, K., Bryon, A., … Yewhalaw, D. 
(2017). Mapping insecticide resistance and characterization of resistance mechanisms 
in Anopheles arabiensis (Diptera: Culicidae) in Ethiopia. Parasites and Vectors, 10(1), 
1–11. https://doi.org/10.1186/s13071-017-2342-y 
AMP. (2017),  LLIN procurement and pipeline monitoring, 1–14. 
Atieli, F. K., Munga, S. O., Ofulla, A. V., & Vulule, J. M. (2010). Wash durability and optimal 
drying regimen of four brands of long-lasting insecticide-treated nets after repeated 
washing under tropical conditions. Malaria Journal, 9(1), 1–10. https://doi.org/10.1186/ 
1475-2875-9-248 
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., & Dalrymple, U. (2015). The 
effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. 
Nature, 526(7572), 207–211. https://doi.org/10.1038/nature15535.The 
Bonner, K., Mwita, A., Mcelroy, P. D., Omari, S., Mzava, A., Lengeler, C., … Brown, N. 
(2011). Design , implementation and evaluation of a national campaign to distribute nine 
million free LLINs to children under five years of age in Tanzania. Malaria Journal, 1–
12. https://doi.org/doi:10.1186/1475-2875-10-73 
Churcher, T. S., Lissenden, N., Griffin, J. T., Worrall, E., & Ranson, H. (2016). The impact of 
pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in 
Africa, 1–26. https://doi.org/10.7554/eLife.16090 
Gleave, K., Lissenden, N., Richardson, M., Choi, L., & Ranson, H. (2018). treated nets to 
32 
prevent malaria in Africa ( Review ). https://doi.org/10.1002/14651858. 
Gleave, K., Lissenden, N., Richardson, M., & Ranson, H. (2017). Piperonyl butoxide ( PBO ) 
combined with pyrethroids in long- lasting insecticidal nets ( LLINs ) to prevent malaria 
in Africa ( Protocol ), (8). https://doi.org/10.1002/14651858.CD012776. 
Gomes de Mattos, R., Oliveira, F., Leiras, A., Baptista de Paula Filho, A., & Gonçalves, P. 
(2018). Robust optimization of the insecticide-treated bed nets procurement and 
distribution planning under uncertainty for malaria prevention and control. Annals of 
Operations Research. https://doi.org/10.1007/s10479-018-3015-8 
Hoibak, S. (2019). Sustaining gains, moving beyond scale-up. https://allianceformalaria 
prevention.com/wp-content/uploads/2015/09/AMP-Toolkit-2.0-Ch10-Sustaining gains 
.pdf 
Jaramillo, G. I., Robledo, P. C., Mina, N. J., Muñoz, J. A., & Ocampo, C. B. (2011). Comparison 
of the efficacy of long-lasting insecticidal nets under laboratory conditions. Mem Inst 
Oswaldo Cruz, 106(August), 606–612. 
Kabula. (2014). Distribution and spread of pyrethroid and DDT resistance among the Anopheles 
gambiae complex in Tanzania, 244–252. https://doi.org/10.1111/mve.12036 
Karakuş, M., Kasap, Ö. E., Günay, F., Oğuz, G., Demir, S., Suner, A., … Özbel, Y. (2016). 
Effects of environmental factors and storage conditions on the performance of Olysetw 
Plus against sand flies in WHO cone bioassays. Transactions of the Royal Society of 
Tropical Medicine and Hygiene, 110(4), 252–257. https://doi.org/10.1093/trstmh/trw 
019 
Kaufmann, C. (2014). Methods in Anopheles Research. Mosquito News, (4), 343. 
Khanam, F., Hossain, M. B., Chowdhury, T. R., Rahman, M. S., Kabir, M., Naher, S., … 
Rahman, M. (2018). Exploring the gap between coverage, access, and utilization of 
long-lasting insecticide-treated nets (LLINs) among the households of malaria endemic 
districts in Bangladesh. Malaria Journal, 17(1), 1–12. https://doi.org/10.1186/s12936 
018-2610-0 
33 
Kilian, A., Koenker, H., & Paintain, L. (2013). Estimating population access to insecticide-
treated nets from administrative data: Correction factor is needed. Malaria Journal, 
12(1), 1–10. https://doi.org/10.1186/1475-2875-12-259 
Kilian, A., Woods Schnurr, L., Matova, T., Selby, R. A., Lokko, K., Blaufuss, S., … Lynch, M. 
(2017). Evaluation of a continuous community-based ITN distribution pilot in Lainya 
County, South Sudan 2012-2013. Malaria Journal, 16(1), 1–13. https://doi.org/10. 
1186/s12936-017-2020-8 
Killeen, G. F., Okumu, F. O., N’Guessan, R., Coosemans, M., Adeogun, A., Awolola, S., … 
Corbel, V. (2011). The importance of considering community-level effects when 
selecting insecticidal malaria vector products. Parasites and Vectors, 4(1), 1–7. 
https://doi.org/10.11 86/1756-3305-4-160 
Kisinza, W. N., Nkya, T. E., Kabula, B., Overgaard, H. J., Massue, D. J., Mageni, Z., … Magesa, 
S. (2017). Multiple insecticide resistance in Anopheles gambiae from Tanzania: A major 
concern for malaria vector control. Malaria Journal, 16(1), 1–10.  
Kleinschmidt, I., Bradley, J., Knox, T. B., Mnzava, A. P., Kafy, H. T., Mbogo, C., … Donnelly, 
M. J. (2018). Implications of insecticide resistance for malaria vector control with long-
lasting insecticidal nets: a WHO-coordinated, prospective, international, observational 
cohort study. The Lancet Infectious Diseases, 18(6). https://doi.org/10.1016/S1473-
3099(18)30172-5 
Koenker, H. (2018). More is More: Are We Delivering Enough LLINs ? EClinicalMedicine, 1, 
5–6. https://doi.org/10.1016/j.eclinm.2018.07.005 
Koenker, H., Arnold, F., Ba, F., Cisse, M., Diouf, L., Eckert, E., … Kilian, A. (2018). Assessing 
whether universal coverage with insecticide-treated nets has been achieved: Is the right 
indicator being used? Malaria Journal, 17(1), 1–11. https://doi.org/10.1186/s12936-
018-2505-0 
Komazawa, O., Kaneko, S., Opiyo, J. K., Kiche, I., Wanyua, S., Shimada, M., & Karama, M. 
(2012). Are Long-Lasting Insecticidal Nets Effective for Preventing Childhood Deaths 
34 
among Non-Net Users ? A Community-Based Cohort Study in Western Kenya, 7(11), 
1–13. https://doi.org/10.1371/journal.pone.0049604 
Kramer, K., Mandike, R., Nathan, R., Mohamed, A., Lynch, M., Brown, N., … Lengeler, C. 
(2017). Effectiveness and equity of the Tanzania National Voucher Scheme for 
mosquito nets over 10 years of implementation. Malaria Journal, 1–13. 
https://doi.org/10.1186/s 12936-017-1902-0 
Krezanoski, P. J. (2016). Delivering insecticide-treated nets for malaria prevention : innovative 
strategies. Dovepress Journal, 39–47. 
Mahande, A. M., Msangi, S., Lyaruu, L. J., & Kweka, E. J. (2018). Bio-efficacy of DuraNet® 
long-lasting insecticidal nets against wild populations of Anopheles arabiensis in 
experimental huts, Tropical Medicine and Health, 5, 1–8. https://doi.org/10.1186/s411 
82-018-0118-5 
Massue, D. J., Lorenz, L. M., Moore, J. D., Ntabaliba, W. S., Ackerman, S., Mboma, Z. M., … 
Moore, S. J. (2019). Comparing the new Ifakara Ambient Chamber Test with WHO 
cone and tunnel tests for bioefficacy and non ‑ inferiority testing of insecticide ‑ treated 
nets. Malaria Journal, 1–15. https://doi.org/10.1186/s12936-019-2741-y 
Matiya, D. J., Philbert, A. B., Kidima, W., & Matowo, J. J. (2019). Dynamics and monitoring 
of insecticide resistance in malaria vectors across mainland Tanzania from 1997 to 2017: 
A systematic review. Malaria Journal, 18(1), 1–16. https://doi.org/10.1186/s12936-
019-2738-6 
Omonijo, A. (2019). Assessment of the Status of Awareness , Ownership , and Usage of Long-
Lasting Insecticide Treated Nets after Mass Distribution in Ekiti State , Nigeria.  Journal 
of Parasitology Research, 2019. https://doi.org/10.1155/2019/1273714 
Peck, G. W., Ferguson, H. J., Lepage, J. T., Hebert, V. R., O’Neal, S. D., & Walsh, D. B. (2014). 
Evaluation of sunlight-exposed pyrethroid-treated netting for the control of face fly and 




Protopopoff, N., Mosha, J. F., Lukole, E., Charlwood, J. D., Wright, A., Mwalimu, C. D., … 
Rowland, M. (2018). Effectiveness of a long-lasting piperonyl butoxide-treated 
insecticidal net and indoor residual spray interventions, separately and together, against 
malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised 
controlled, two-by-two fact. The Lancet, 391(10130), 1577–1588. https://doi.org/10.10 
16/S0140-6736(18) 30427-6 
Pryce, J., Richardson, M., & Lengeler, C. (2018). Insecticide-treated nets for preventing 
malaria, (11). https://doi.org/10.1002/14651858.CD000363.pub3. 
Rafinejad, J., Vatandoost, H., Nikpoor, F., Abai, M. R., Shaeghi, M., Duchen, S., & Rafi, & F. 
(2008). Effect of washing on the bioefficacy of insecticide-treated nets (ITNs) and long-
lasting insecticidal nets (LLINs) against main malaria vector Anopheles stephensi by 
three bioassay methods. Journal of  Vector Borne Diseases (Vol. 45). 
Raghavendra, K., Chourasia, M. K., Swain, D. K., Bhatt, R. M., Uragayala, S., Dutta, G. D. P., 
& Kleinschmidt, I. (2017). Monitoring of long-lasting insecticidal nets (LLINs) 
coverage versus utilization: A community-based survey in malaria endemic villages of 
Central India. Malaria Journal, 16(1), 1–8. https://doi.org/10.1186/s12936-017-2117-0 
Ranson, H., Guessan, R. N., Lines, J., Moiroux, N., Nkuni, Z., & Corbel, V. (2011). Pyrethroid 
resistance in African anopheline mosquitoes : what are the implications for malaria 
control ? Trends in Parasitology, 27(2), 91–98. https://doi.org/10.1016/j.pt.2010.08.004 
RBM. (2016). Health Facility-Based Distributions of Long-Lasting Insecticidal Nets A Short 
Guide Based on Recent Country Experience, (December). 
Shi, P., & Tsai, C. L. (2002). Regression model selection - A residual likelihood approach. 
Journal of the Royal Statistical Society. Series B: Statistical Methodology, 64(2), 237–
252. https://doi.org/10.1111/1467-9868.00335 
Silva, A. P. B., Santos, J. M. M., & Martins, A. J. (2014). Mutations in the voltage-gated sodium 
channel gene of anophelines and their association with resistance to pyrethroids – a 
review. Parasites & Vectors, 1–14. http://www.parasitesandvectors.com/content/7/1/45 
36 
0 
Toto, H., Adam, B., Peter, A., & Lines, J. (2017). Impact of insecticide resistance in Anopheles 
arabiensis on malaria incidence and prevalence in Sudan and the costs of mitigation. 
PNAS, 1–9. https://doi.org/10.1073/pnas.1713814114. 
USAID. (2014). Long-Lasting Insecticide-Treated Bed Net Packaging Considerations, 9. 
Retrieved from http://deliver.jsi.com/dlvr_content/resources/allpubs/logisticsbriefs/ 
LLIN PackCons.pdf. 
WHO-PQ. (2018). List of WHO Prequalified Vector Control Products, (001), 1–5. Retrieved 
from https://www.who.int/pq-vector-control/prequalified-lists/PQT_VC_17July2018. 
pdf?ua=1 
WHO/ GMP. (2016). Test procedures for insecticide resistance monitoring in malaria vector 
mosquitoes, Second edition. World Health Organisation Technical Report Series, 22. 
WHO/GMP. (2017). Achieving and maintaining universal coverage with long-lasting 
insecticidal nets for malaria control. World Health Organization. 
WHO. (2009). Report of the Thirteenth Whopes Working Group Meeting. World Health 
Organization, 5, 1–73. 
WHO. (2013a). Guidelines for laboratory and fiel-testing of long-lasting insecticidal nets. 
WHO. (2013b). Vector Control Technical Expert Group Report to MPAC September 2013. 
World Health Organization. 
WHO. (2014a). Estimating population access to ITNs versus quantifying for procurement for 
mass campaigns, (March), 2013–2014. 
WHO. (2014b). WHO specifications and evaluations for public health pesticides permethrin- 
incorporated into filaments, 1–21. 
WHO. (2015a). Global technical strategy for malaria 2016-2030. World Health Organization. 
37 
WHO. (2015b). Specifications and Evaluations for Public Health Pesticides Deltamethrin Long-
Lasting, 1–96 WHO. 
WHO. (2018). World Malaria Report, World Health Organization. 
WHO. (2019). Guidelines for malaria vector control, World Health Organization. 
38 
APPENDICES 
Appendix 1. Informed consent for I-ACT volunteers 
Information sheet and informed consent for participants sleeping in Ambient Chambers 
in English  
INFORMED CONSENT FORM FOR PARTICIPANTS 
Name of Principle Investigator: Mr. Jeremiah John Musa 
Name of Organization: Ifakara Health Institute, Bagamoyo, Tanzania 
Project code: BIT LS Nets   
PART 1. INFORMATION SHEET FOR PARTICIPANTS 
Phase II evaluation of Long storage nets compared to new nets of the same brand; 
DawaPlus® 2.0 LN and Olyset® LN® against strongly pyrethroid resistant Anopheles 
arabiensis and fully pyrethroid susceptible Anopheles gambiae s.s (Ifakara strain) in the 
Ifakara Ambient Chamber test, Tanzania 
Introduction 
My name is ………………. (Name of investigator), I am working for Ifakara Health Institute, 
Tanzania. We are trying to evaluate the efficacy of long storage nets; DawaPlus® 2.0 LLIN and 
Olyset® LLIN and compare their efficacy with new nets of the same brand respectively. They 
are all approved for use by the World Health Organization for malaria control. The Government 
of Tanzania through the Tropical Pesticides Research Institute (TPRI) has also approved the 
nets for us to research in Tanzania. 
Purpose of research 
Malaria is one of the most important diseases in Tanzania. It is spread from one person to 
another through infected bites of certain mosquitoes. These mosquitoes normally bite at night. 
It has been shown that sleeping under mosquito nets can help to avoid getting bitten in the night. 
Furthermore, if the nets are treated with some chemicals that kill insects (insecticides), then 
they will prevent the bites and also kill the mosquitoes. Therefore, if everybody in the 
community sleeps under insecticide treated nets, they provide control of the mosquitoes. Some 
kinds of nets are given a special chemical treatment in the factory and do not require re-
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treatment until the end of their useful life; these are called long-lasting insecticidal mosquito 
nets (LLINs). DawaPlus® 2.0 (rebranded Tsara Soft) and Olyset® are names of such long-
lasting insecticidal mosquito net brands.   
There is a need to evaluate the efficacy of unwashed and washed long storage nets: DawaPlus® 
2.0 and Olyset® in the Ambient Chambers, to find out if they remain effective against malaria-
transmitting mosquitoes after they have been stored for a long period of time without domestic 
use (> 5 years) and compared their efficacy with new unwashed and washed nets of the same 
brand respectively.  
We would like to invite you as a participant in this study. Two types of nets will be tested in the 
Ambient Chambers to find out their mosquito killing/malaria prevention properties. As a 
participant you will sleep under the bed nets in the Ambient Chambers. These have holes in 
them. Then you will be required to collect mosquitoes from your chamber each morning. 
Neither our research team nor you know which net which is, but it will either be DawaPlus® 
2.0 or Olyset®. 
Information on study nets 
In this study selected nets are factory-treated ones. DawaPlus® 2.0 (currently Tsara soft) is 
manufactured by NRS Moon Netting FZE, Pakistan and Olyset® is manufactured by A to Z 
Textile Mills Limited, Arusha Tanzania. These products have been tested by the World Health 
Organization (WHO) and Tanzania Pesticide Research Institute (TPRI) and are recommended 
as being safe and effective against malaria for all people to use. 
Type of Research Intervention and procedures 
 As a participant you will be asked to sleep under the bed nets between 2100 h and 0630 h.
 The work will be done in the screen house tunnel with laboratory reared mosquitoes free
of malaria parasites, even if they bite you, you will not get a disease from them.
 You will be asked to sleep in a compartment in the semi-field tunnel. Mosquitoes will be
released into the compartment.
 The bed nets are safe for use on humans and have been approved by the Tropical Pesticide
Research Institute.
 You will be asked to collect the mosquitoes in the compartment at 0630 h each morning
using a siphon.
 You will be asked to not smoke cigarettes or drink alcohol for the days or weeks that you
are participating.
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 You will need to take a malaria test every week that you are working on the study and sign
a form to show that you have taken the test. The test will be paid for by the study. If you
are sick we will provide you with the correct medicine to treat malaria: ALU (Artemisinin
lufantrine) free of charge, and you will no longer allowed to take part in the study because
you are sick.
Voluntary Participation 
Your participation in this research is entirely voluntary. It is your choice whether to participate 
or not. You may change your mind later and stop participating even if you agreed earlier. This 
will not affect your work with IHI. It is your choice and all of your rights will still be respected. 
Risks 
The risk of this study is you may feel uncomfortable due to mosquito bites. You will be provided 
with a bed net so you will not receive many bites, although the bed nets have holes in them. 
There is a small possibility that you may get malaria while participating in the study. Thus, if 
you suffer from fever, you should immediately seek for advice/assistance from the Ifakara 
Health Institute personnel as per the contact details given below.  
Deltamethrin and permethrin, the insecticides used on the nets, has been tested before and has 
not been found to have any undue adverse effects in most people at the dose found on the nets. 
Some tingling or runny nose has been recorded in some people when nets are used for the first 
time when taken from its package. There is no cause for alarm as these effects pass within a day 
or two. In some people, the use of treated nets may also cause other adverse effects during the 
first few days of their use such as headache, numbness, and itching, sneezing, discharge from 
eyes, nausea, and unpleasant smell. We will ask you for these symptoms, as well as should you 
perceive any adverse effects of using the nets, please consult a doctor at the local health facility 
or report this to one of our staff immediately at the contact details given below and we will 
provide you with all the necessary medical care.  
Benefits 
If you participate in this research, you will have the following benefits: You will be given 
weekly screening for malaria and treatment if you have parasites. You will also be helping 
the development of better bed nets that people like to use by providing information on the 
effectiveness of new products.  
Compensation 
You will receive Tshs 15,000 for your time away from home each night of the experiment. 
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Who to contact 
This proposal has been reviewed and approved by the Ethics Committee of IHI and NIMR, 
Tanzania, which is a committee whose task it is to make sure that research participants are 
protected from harm.  
In case you have any question or concern about this study please feel free to contact Mr. 
Jeremiah J Musa, Study Investigator (Tel: +255 789 000 916) and Dr. Sarah Moore, Senior 
Research Scientist/Study Director (Tel. No. +255 764 802 622) at IHI.   
However, if you are not satisfied with responses given by the study team, feel free to contact 
the representative of IHI institutional review board Dr. Mrisho Mwifadhi, (Telephone: +255 
788 766 676), or Ms. Sia Malekia, (Telephone: +255 754 499 293) National Institute of Medical 
Research (NIMR). 
We are leaving with you a copy of this informed consent form for your information and future 
reference. 
PART II: Certificate of Consent 
I ………………………………………………. clearly understand the aims of the project 
entitled  
 “Phase II Bio-efficacy evaluation of Long-Lasting Insecticidal nets after five years of 
storage (DawaPlus® 2.0 LN and Olyset®)  against strongly pyrethroid resistant Anopheles 
arabiensis and fully pyrethroid susceptible Anopheles gambiae s.s. in the Ifakara Ambient 
Chamber test, Tanzania” and I agree to participate in the study. During my participation in 
these studies, I understand that working at night may expose me to increased risk of infection 
with malaria. I therefore undertake to submit to weekly screening for malaria parasites by RDT. 
I also understand that I am entitled to free malaria prophylaxis and treatment for malaria if found 
to be infected with malaria parasites. I understand that I may revoke my consent and leave the 
study at any time. 
Participant Name: _____________________________________________ 
Participant Signature: ______________________Date ________________DD/MM/YY 
Witness Name: _______________________________________________________ 
Witness signature: ___________________________Date______________ DD/MM/YY) 
42 
If illiterate 
I have witnessed the accurate reading of the consent form to the potential participant, and the 
individual has had the opportunity to ask questions. I confirm that the individual has given 
consent freely.  
Print name of witness_____________________    AND Thumb print of participant 
Signature of witness ______________________ 
Date ________________________DD/MM/YY) 
Statement by the researcher/person taking consent 
I have accurately read out the information sheet to the potential participant, and to the best of 
my ability made sure that the participant understands that the following will be done: 
1. The participant has been requested to sleep under a bed net between 21:00 hrs and 06:30
hrs.
2. The participant has been informed that work will be done in the screen house tunnel so the
mosquitoes do not have malaria cannot transmit disease even if they bite participants.
3. The participant has been requested to sleep in a compartment in the semi-field tunnel.
Mosquitoes will be released into the compartment.
4. The participant has been informed that the bed nets are safe for use on humans and has been
approved by the Tropical Pesticide Research Institute.
5. The participant has been requested to collect the mosquitoes in the compartment at 06.30
hours each morning using a siphon.
6. Participant has been requested to refrain from smoking and consuming alcohol for the study
duration.
7. Participant has been requested to take a malaria test every week that they are working on
the study and sign a form to show that they have taken the test
8. Participant has been informed that malaria testing and treatment will be paid for by the
study.
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9. Participant has been informed that if they test positive for malaria, they will not be allowed
to take part in the study.
10. Participant will be reimbursed 15,000 Tshs per night for work time taken up by the study
I confirm that the participant was given an opportunity to ask questions about the study, and all 
the questions asked by the participant have been answered correctly and to the best of my ability. 
I confirm that the individual has not been coerced into giving consent, and the consent has been 
given freely and voluntarily.    
I confirm that a copy of this ICF has been provided to the participant. 
Print Name of Researcher/person taking the consent________________________ 
Signature of Researcher /person taking the consent__________________________ 
Date ___________________________DD/MM/YYYY 
